S100A9 and cancer: Notably, analysis of TCGA Pan-Cancer Atlas showed a consistent positive correlation between SERPINB3 and CXCL1, CXCL8, S100A8, and S100A9 across multiple tumor types including bladder, breast, head and neck, lung, prostate, and uterine cancers (Figure 1H).